Chi Van Dang

28PUBLICATIONS
94CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Tō te Māori mātauranga hangarau, mātauranga atu anō, mātauranga haere tonu, me te mātauranga hapori (Māori technical, further, continuing and community education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|Jan 18, 2025
Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets.

Nathan M Kendsersky, Michal Odrobina, Nathaniel W Mabe

|Jul 31, 2024
The Warburg Effect Revisited through Blood and Electron Flow.

Yahui Wang, Chi V Dang

|Jul 15, 2024
Hypermetabolic state is associated with circadian rhythm disruption in mouse and human cancer cells.

Daniel Maxim Iascone, Xue Zhang, Patricia Brafford

|Jun 26, 2024
Clocking Cancer Immunotherapy Responses.

Catherine L Wang, Xue Zhang, Chi V Dang

|Jan 20, 2024
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity.

Xue Zhang, Shishir M Pant, Cecily C Ritch

Pageof 5

Frequent Collaborators

9 joint publications

Kenneth C Anderson

9 joint publications

Raymond N DuBois

9 joint publications

Lewis C Cantley

9 joint publications

Keith T Flaherty